Clinical Trial Update: Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo [NA]

View source ↗

Summary

A completed clinical trial comparing vascular reactivity in chronic kidney disease patients treated with paricalcitol versus placebo; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Amy Barton Pai | Conditions: Chronic Kidney Disease | NA | Status: COMPLETED | Results posted: 2016-12-02